Frontlight ResearchEarly access
Polycystic kidney disease trials in Switzerland
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleHYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
- Where
- Bern, Fribourg, Geneva, Zurich
- Age
- 18 years to 80 years
- People
- 300 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT05373264 · EU 2022-500210-26-00